Supplementary Figure 1 from Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade–resistant Melanoma for Anti-PD-L1 Rechallenge

Authors:

Abstract
Supplementary Figure 1 shows Whole blood cell counts at baseline, week 9 and week 22